CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL)

Historical Holders from Q1 2014 to Q3 2025

Symbol
CRL on NYSE
CUSIP
159864107
Type / Class
Equity / Common Stock, $0.01 par value per share
Shares outstanding
50.5M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
50.3M
Holdings value
$7.91B
% of all portfolios
0.005%
Grand Portfolio weight change
0%
Number of holders
532
Number of buys
276
Number of sells
-235
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 6.9% $352M 3.52M BlackRock, Inc. Mar 31, 2025
WELLINGTON MANAGEMENT GROUP LLP 6.5% -23.8% $499M -$171M 3.19M -25.5% Wellington Management Group LLP Sep 30, 2025
NOMURA HOLDINGS INC 1.6% -76% $126M -$293M 808K -69.9% NOMURA HOLDINGS INC Sep 30, 2025

Institutional Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 50.3M $7.91B -$79.2M $156.46 532
2025 Q2 50.8M $7.72B -$316M $151.73 510
2025 Q1 53M $7.96B -$132M $150.52 554
2024 Q4 53M $9.77B +$238M $184.60 625
2024 Q3 51.5M $10.1B -$16.1M $196.97 622
2024 Q2 52.4M $10.8B +$46.4M $206.58 652
2024 Q1 51.7M $14B -$13.2M $270.95 662
2023 Q4 557K $132M -$3.15M $236.40 6
2023 Q3 50.4M $9.86B +$147M $195.98 603
2023 Q2 50.6M $10.6B -$29.7M $210.25 597
2023 Q1 50.4M $10.2B +$259M $201.82 601
2022 Q4 49.4M $10.8B -$104M $217.90 606
2022 Q3 44.6M $8.79B +$296M $196.80 554
2022 Q2 48.3M $10.3B +$408M $213.97 602
2022 Q1 47.4M $13.5B +$106M $283.97 620
2021 Q4 46.7M $17.6B +$196M $376.78 689
2021 Q3 46.7M $19.3B -$271M $412.67 665
2021 Q2 46.6M $17.3B +$133M $369.92 622
2021 Q1 46.7M $13.5B +$147M $289.83 551
2020 Q4 46.8M $11.7B +$73.1M $249.86 530
2020 Q3 46.2M $10.5B +$23.1M $226.45 482
2020 Q2 43.5M $7.52B -$106M $174.35 449
2020 Q1 46.2M $5.83B -$75.1M $126.21 399
2019 Q4 46.9M $7.17B +$24.3M $152.76 399
2019 Q3 46.4M $6.15B +$103M $132.37 388
2019 Q2 46.1M $6.55B +$153M $141.90 395
2019 Q1 46.2M $6.7B +$95.9M $145.25 400
2018 Q4 45.4M $5.14B -$151M $113.18 399
2018 Q3 46.3M $6.22B +$101M $134.54 362
2018 Q2 46.3M $5.19B -$31.3M $112.26 342
2018 Q1 47.2M $5.03B +$1.9M $106.74 328
2017 Q4 47.2M $5.16B +$108M $109.45 335
2017 Q3 45.9M $4.96B -$9.17M $108.02 331
2017 Q2 45.8M $4.63B -$88.2M $101.15 295
2017 Q1 46.7M $4.2B +$352M $89.95 293
2016 Q4 45.8M $3.49B -$19.9M $76.19 291
2016 Q3 45.7M $3.8B +$8.78M $83.34 275
2016 Q2 45.9M $3.79B -$25.6M $82.44 275
2016 Q1 46.8M $3.56B +$139M $75.94 258
2015 Q4 44.9M $3.61B -$42.2M $80.39 260
2015 Q3 46M $2.92B -$39.1M $63.52 253
2015 Q2 46.3M $3.25B -$16.4M $70.34 259
2015 Q1 46.7M $3.7B +$55.8M $79.29 256
2014 Q4 46.3M $2.95B +$20.4M $63.64 251
2014 Q3 46.7M $2.79B -$86M $59.74 254
2014 Q2 47.4M $2.54B -$9.68M $53.52 258
2014 Q1 47.6M $2.87B +$86.3M $60.34 256